More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during ...

The child is currently being treated at a trust-run hospital and his condition is stable, a medical officer said ...

A 4-year-old boy from Ahmedabad city has contracted human metapneumovirus, taking the number of HMPV cases in Gujarat to ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

COVID-19 has been more prevalent and has caused more deaths than flu or respiratory syncytial virus (RSV) in the last three years, according to a study on American veterans published Monday in JAMA ...

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory illness increased to 4.92 per cent by the middle of January 2025. This is ...